DEBORA TENTER: Open Payments
NPI 1467804567 · SAINT JOSEPH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 54 payments from 15 companies in 2025. Trend: 2023 $215 · 2024 $616 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $197 |
| Vanda Pharmaceuticals Inc. | 9 | $180 |
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| ABBVIE INC. | 6 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Viatris Specialty LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Lundbeck LLC | 2 | $54 |
| Novo Nordisk Inc | 2 | $53 |
Products named: CAPLYTA, FANAPT, AIRSUPRA, REXULTI, Auvelity, VRAYLAR, YUPELRI, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
